Australian asthma deaths fall, mostly in women: ABS

The National Asthma Council has highlighted the vital role community pharmacists can play in identifying at-risk patients, following a drop in overall asthma deaths...

Care without caps

Rural Victorian pharmacist Kelly Abbott MPS reaches her 30 HMR cap every month, continuing to advocate for person-centred care.

Pharmacy Board’s measured step on prescribing

The Pharmacy Board of Australia has recognised that pharmacists should be able to prescribe under two monitored models of prescribing, in a move welcomed...

Quick Q&A with Katherine Higgins MPS

Jennifer Cooke, the Editor of Australian Pharmacist, talks with Katherine Higgins, a pharmacist in South Perth, Western Australia.

The impact of air pollution

Air pollution is making us sick according to local and global research, including a study linking exposure to air pollution with subsequent acute cardiac...

Efficacy of antiplatelets in deep venous thrombosis

Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.